This inventor holds 1 USPTO granted patent. Top assignee: Spofa, Spojene Podniky Pro Zdravotnickou Vyrobu. Active years: 1987.
Company Filing History:
Years Active: 1987
Title: Martin Cerny: Innovator in Peptide Analog Research
Introduction
Martin Cerny is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of peptide research, particularly through his innovative work on serum thymic factor peptide analogs. His research has implications for various medical applications, showcasing the importance of peptide analogs in therapeutic contexts.
Latest Patents
Cerny holds a patent for "Serum thymic factor peptide analogs and process for the preparation." This patent discloses novel peptide analogs of the serum thymic factor, which are structurally modified compared to the natural substance. The modifications occur in both the N-terminal and C-terminal parts, as well as within the amino-acid sequence, corresponding to the general formula I. This patent highlights his expertise in the synthesis and application of peptide analogs.
Career Highlights
Throughout his career, Martin Cerny has been associated with Spofa, Spojene Podniky Pro Zdravotnickou Vyrobu, a company dedicated to health product manufacturing. His work at Spofa has allowed him to focus on innovative research and development in the field of biochemistry and pharmaceuticals. Cerny's contributions have been instrumental in advancing the understanding and application of peptide analogs.
Collaborations
Cerny has collaborated with notable colleagues such as Evzen Kasafirek and Petr Kocis. These collaborations have fostered a productive research environment, leading to advancements in peptide research and development.
Conclusion
Martin Cerny is a distinguished inventor whose work on serum thymic factor peptide analogs has made a significant impact in the field of biochemistry. His innovative research continues to pave the way for future advancements in medical applications.